GE HealthCare's Growth Target Remains Unchanged Amid Margin Pressures and Quarterly Profit Dip

GE HealthCare Technologies reported Q3 2025 revenue of $5.14 billion and net income of $446 million, down from last year. Despite ongoing concerns about trade pressures and margin challenges, the company reaffirmed its full-year 2025 organic revenue growth target. The reaffirmation suggests that short-term catalysts, such as product rollouts and market expansions, remain intact, while the impact of escalating U.S.–China tariffs remains unchanged.